Drug Topics August 21, 2024
Research experts at the Brookings Institution in Washington, D.C., analyzed the savings estimates provided by CMS for its drug price negotiations and compared them with the institution’s own estimates.
The first 10 drugs selected for price negotiations under the Inflation Reduction Act (IRA) of 2022 were recently announced and researchers from the Brookings Institution compared savings estimates provided by the Centers for Medicare and Medicaid Services (CMS) with their own. After using publicly available data to find their estimates, researchers confirmed the consistency of CMS in drug price negotiations and savings estimates. However, they found that 51.4% of estimated savings, over $3 billion, were for just 3 of the 10 drugs selected.
“The much anticipated first set of negotiations on...
Today's Sponsors
Today's Sponsor